Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Teresa, Nadal"'
Autor:
Anna Solans, Iñaki Izquierdo, Manel J. Barbanoj, Teresa Nadal, Esther Donado, Marcel-lí Carbó, Manuel Merlos, Juana Peña, Rosa M. Antonijoan
Publikováno v:
Clinical Therapeutics. 30:1639-1650
Background: Rupatadine is an oral active antihistamine and platelet-activating factor antagonist indicated for the management of allergic rhinitis and chronic urticaria in Europe. Objective: The purpose of this study was to describe the effect of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2765dfe8c58414b01eadda9861dd9d41
https://doi.org/10.1016/j.clinthera.2008.09.002
https://doi.org/10.1016/j.clinthera.2008.09.002
Publikováno v:
Journal of Chromatography A. 721:127-137
A rapid, simple and sensitive method is described for the simultaneous determination in human plasma of the well known antiviral agent zidovudine (AZT) and its main metabolite, zidovudine-5′-O-glucuronide (G-AZT), using a solid-phase extraction met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2e005006427fd6a8aac60ab9922fb6
https://doi.org/10.1016/0021-9673(95)00472-6
https://doi.org/10.1016/0021-9673(95)00472-6
Publikováno v:
Journal of Chromatography A. 655:233-242
A method to detect the presence of diuretics, probenecid and other agents of doping interest (morazone, mesocarb, caffeine) in urine was developed. The extraction procedure was optimized to obtain adequate recoveries of the compounds under study. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a871e1a1a45507c5d002f1b804595eba
https://doi.org/10.1016/0021-9673(93)83228-k
https://doi.org/10.1016/0021-9673(93)83228-k
Publikováno v:
Journal of Chromatography A. 647:203-210
A method of screening for mesocarb ingestion in doping control is described. After alkaline extraction with ethyl acetate, samples are analysed by reversed-phase high-performance liquid chromatography (HPLC) with UV detection. A peak with a shorter r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1da53cce150c6d14a349f95e33bc6e0d
https://doi.org/10.1016/0021-9673(93)83402-e
https://doi.org/10.1016/0021-9673(93)83402-e
Publikováno v:
Scopus-Elsevier
Rupatadine is a new oral antihistaminic agent used for the management of allergic inflammatory conditions, such as rhinitis and chronic urticaria. The aim of the present study was to develop a population pharmacokinetic/pharmacodynamic (PKPD) model f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb164fa3cd54e8e4e4bb8d54ba24f85
https://pubmed.ncbi.nlm.nih.gov/18777946
https://pubmed.ncbi.nlm.nih.gov/18777946
Publikováno v:
Clinical therapeutics. 29(5)
Background: Rupatadine is an oral active antihistamine for the management of diseases with allergic inflammatory conditions, such as perennial and seasonal rhinitis and chronic idiopathic urticaria. Oral rupatadine has been approved for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9de6fd1b6edbd19b147d0d990db974
https://pubmed.ncbi.nlm.nih.gov/17697908
https://pubmed.ncbi.nlm.nih.gov/17697908
Autor:
Francis, Paolucci, Helma, Frasa, Frank, Van Aarle, Anna, Capdevla, Marie-Christine, Clavies, Theo, van Dinther, François, Donat, Yvonne, Hendriks, Michiel, van den Heuvel, Teresa, Nadal, Fabrice, Lagrange, Joseph, Necciari, Yolanda, Perez
Publikováno v:
Clinical laboratory. 49(9-10)
Fondaparinux is a synthetic selective inhibitor of factor Xa recently approved for thromboprophylaxis after major orthopedic surgery. Determination of its concentration gives valuable insight into specific pharmacokinetics or safety studies. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80303b5e87a329836200787576cad34b
https://pubmed.ncbi.nlm.nih.gov/14572200
https://pubmed.ncbi.nlm.nih.gov/14572200
Autor:
Bernard Bannwarth, Francis Paolucci, Jean-Luc Brun, Jean-Joël Leng, Marie Claude Saux, Teresa Nadal, Marie Christine Vergnes, Fabrice Lagrange
Publikováno v:
Clinical pharmacokinetics. 41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b4df75c17085f31125325268225e8a
https://pubmed.ncbi.nlm.nih.gov/12383045
https://pubmed.ncbi.nlm.nih.gov/12383045